It has been established previously that nephrotic hyperlipidemia is characterized by both an increase in lipid synthesis and a defect in removal of lipoproteins. The relationship between these defects and altered albumin metabolism is uncertain. One hypothesis is that hepatic lipogenesis increases in parallel with albumin synthesis. To test this hypothesis, albumin synthesis was increased in nephrotic rats fed an 8.5% protein diet (LPN) by increasing dietary protein to 40% (HPN). Proteinuria was modulated in half of the rats fed 40% protein by enalapril (HPE). Albumin synthesis was the same in both HPN and HPE, but proteinuria was reduced in HPE compared to HPN, and so were serum cholesterol and triglycerides (TG). To examine the effect of serum albumin on lipid clearance in the absence of proteinuria, plasma clearance of chylomicrons (CM) and VLDL was measured in Nagase analbuminemic rats (NAR) and found to be no different than in normal SD rats. When proteinuria was induced in NAR and in SD rats, a severe and identical defect in both CM and VLDLL clearance was acquired in both groups and blood lipid levels were increased to a similar degree in both groups. Neither hyperlipidemia nor defective removal of lipoproteins from the circulation are linked to albumin synthesis or serum albumin concentration but result, at least in part, from proteinuria. Postheparin lipoprotein lipase (LPL) activity was reduced slightly in nephrotic animals compared to nonnephrotic controls, but the most striking finding was a highly significant decrease in postheparin LPL activity in normal NAR compared to SD rats (P < 0.001), suggesting that reduced LPL activity is not responsible for reduced clearance of CM and VLDL in nephrotic rats. (J. Clin. Invest. 1990. 86:500-505.)
Introduction
Hyperlipidemia and hypoproteinemia are hallmarks of the nephrotic syndrome. There is general agreement that the clear-ance of circulating lipids, specifically chylomicrons (CM)' (1, 2) and VLDL is reduced (3) and hepatic synthesis oflipids and lipoproteins is increased (4, 5) . The nephrotic syndrome results from altered glomerular permselectivity resulting in the urinary loss of macromolecules. As a consequence, serum albumin concentration and oncotic pressure (Xr) are reduced. The relationship between disordered lipid metabolism and these other manifestations ofthe nephrotic syndrome has been a subject of controversy.
Two separate hypotheses have been proposed to establish a relationship between proteinuria and altered lipid metabolism. One postulate is that proteinuria causes reduced serum 7r, which in turn directly stimulates albumin synthesis. The rate of synthesis of all other liver-derived exported proteins, including lipoproteins, is proposed to be increased coordinately with that of albumin since all share a common secretory pathway (6) (7) (8) . This model provides a mechanism for increased lipogenesis in nephrosis, but does not account for deranged lipid removal.
A second hypothesis, proposed by Staprans and Felts was that the urinary loss of a liporegulatory substance caused defective removal oflipids from the circulation. They identified a lipoprotein lipase (LPL) cofactor, heparan sulfate, lost in the urine in the nephrotic syndrome (1, 2) .
The Nagase analbuminemic rat (NAR) is a strain of Sprague Dawley (SD) rat incapable of synthesizing albumin (9) . Albumin is replaced by several larger liver-derived macroglobulins (10, 11) . Serum protein concentration is normal (12) , but serum ir is reduced. Although no urinary protein loss occurs in normal NAR, serum cholesterol and TG are increased (13) (14) (15) . The NAR provides an opportunity to study lipoprotein clearance in animals that have no albumin yet have no defect in glomerular permselectivity. It is also possible to alter glomerular permselectivity in these animals and determine the effect of nonalbumin urinary protein loss on lipid metabolism.
Dietary protein augmentation increases both the rate of albumin synthesis (16) and impairs glomerular permselectivity (17) in SD rats with Heymann nephritis. Treatment with enalapril blunts the proteinuric effect of dietary protein augmentation, but not the stimulation of albumin synthesis (18) . Thus it is possible to independently modulate albumin synthesis and glomerular permselectivity in nephrotic SD rats and determine whether an enhanced rate of albumin synthesis would increase blood lipid levels independent of changes in proteinuria.
We report here the relationship between albumin synthesis and blood lipid levels in both nephrotic and normal SD rats as well as the metabolic clearance of both CM and VLDL in normal and nephrotic NAR and SD rats.
Methods
Four separate experimental protocols were performed. In the first protocol CM clearance was compared in normal NAR and SD rats to determine whether the clearance of CM was altered by the absence of serum albumin. Proteinuria was then produced in both SD and NAR rats to determine whether CM clearance became abnormal after an alteration in glomerular permselectivity.
In protocol 2, VLDL clearance was measured in nephrotic and normal NAR and SD rats as in protocol 1. Postheparin LPL activity was then measured in the same animals.
In the third and fourth protocols the relationship between blood lipids and albumin synthesis was evaluated utilizing SD rats with experimental nephrotic syndrome (passive Heymann nephritis) (protocol 3) and normal SD rats (protocol 4). Albumin synthesis was increased by dietary protein augmentation from 8.5 to 40% in both the nonnephrotic and nephrotic groups and the angiotensin-converting enzyme inhibitor enalapril, was used to modulate proteinuria in protocol 3.
Protocol 1: The effect of analbuminemia and proteinuria on CM clearance. 14 Measurement ofpostheparin LPL activity. At the end of measurement of VLDL clearance, animals were allowed free access to food and water for 48 h. They were then anesthetized with sodium pentobarbital, the abdomen was incised and heparin (10 U/kg) was injected into the right femoral vein. Rats were exsanguinated 5 min later from the abdominal aorta for measurement of postheparin LPL. LPL activity was then assayed by measurement of hydrolysis of intralipid (23).
1 ml reaction mixtures consisted of: 0.1 ml of 1.3 M Tris-HCI, pH 8.6; 0.1 ml of 0.025 M NH40H, pH 8.6; 0.3 ml of 15% (wt/vol) crystalline bovine serum albumin (Sigma Chemical Co., St. Louis, MO), 0.1 ml of 10% Intralipid (Vitrum, Stockholm, Sweden), 0.2 ml normal rat serum, and 0.2 ml of postheparin plasma. Duplicate samples were incubated for 60 min at 370C. Free fatty acids (FFA) were extracted and their content was determined by titration with tetrabutyl ammonium hydroxide. Reaction mixtures lacking postheparin plasma were incubated under the same conditions to serve as control blanks. LPL activity was defined in units as micromoles of FFA released/ hour/milliliter of postheparin plasma. When incubation was carried out in the presence of 1 M NaCl, no release of FFA was detected, indicating that this method specifically determined LPL and not hepatic triacylglycerol lipase. (27) (28) (29) . Serum ir was kindly measured for us by Dr. Eugene
Renkin using an oncometer with a PM 30 Amicon membrane (30) . Statistics. All values were analyzed by the omega statistic to determine whether variables were normally distributed. When variables were normally distributed comparisons were performed using a oneway analysis of variance (31) . The Kruskal-Wallis analysis of variance by ranks was used to compare non-normally distributed values. A P value of < 0.05 was considered to be statistically significant. Figs. I and 2 are disappearance curves for chylomicrons and VLDL, respectively. Statistical differences between chylomicron or VLDL metabolism were determined using rate constants rather than t.,, values since the latter are not normally distributed. Multiple regression analysis was performed using Microstat, an interactive program that generates a table of partial correlation coefficients and then analyzes these by a stepwise regression procedure.
Results
The clearance of CM and VLDL from plasma was the same in normal NAR and normal SD rats even though albumin was virtually absent from the serum of normal NAR (Figs. 1 and 2 , Tables I and II) . Serum cholesterol however, was increased significantly in the normal NAR (Table I and II) when compared to normal SD. Serum TG concentration also tended to be greater in the NAR (Table I) . When proteinuria was induced serum cholesterol and TG concentrations increased significantly in both nephrotic SD and NAR (Table I and II) . This increase in blood lipids was accompanied by a large and significant decrease in the clearance of CM and VLDL (Tables  I and II, Figs. 1 and 2 ). As in nonnephrotic animals, CM and VLDL clearance was the same in both groups of nephrotic rats even though albumin was absent from the serum of nephrotic NAR and was present in nephrotic SD.
Postheparin LPL activity was reduced slightly in nephrotic animals compared to nonnephrotic controls, but the most striking finding was a highly significant decrease in postheparin LPL activity in normal NAR when compared to normal SD rats (Table II) Fig. 1 . Normal SD, n = 3. Normal NAR, n = 2. Nephrotic SD, n = 3. Nephrotic NAR, n = 3.
Serum 7r was significantly greater in normal SD than in normal NAR (protocol 1, Table I , P < 0.05), but was similar in both groups of nephrotic animals. Serum TG correlated with CM clearance by multiple regression analysis, while serum cholesterol did not. Serum cholesterol concentration correlated negatively with serum 7r, while serum TG did not.
A 40% protein diet increased albuminuria, renal albumin clearance, and the rate of albumin synthesis in nephrotic rats (HPN), and both serum cholesterol and TG concentrations were greater in these animals when compared to LPN (Table  III) . Enalapril limited the increase in both albuminuria and the renal clearance of albumin, yet the rate of albumin synthesis was no different in HPNE and HPN. Both serum cholesterol and TG were significantly less in HPNE than in HPN although albumin synthesis rate was the same in these two groups. LPN had the lowest rate of albumin synthesis, the least albuminuria and the lowest renal clearance of albumin among the nephrotic animals, yet blood lipids were intermediate between HPN and HPNE.
The rate of albumin synthesis was significantly greater in HPC than in LPC and in HPCE than in LPCE (P < 0.05, phrotic syndrome is therefore not caused by alterations in serum albumin concentration, but instead results from deranged glomerular permselectivity; presumably from the urinary loss of a substance(s) necessary for normal lipid clearance.
The finding that postheparin LPL activity was greatly reduced in normal NAR compared to normal SD, while LPL activity was only slightly decreased in nephrotic animals compared to nonnephrotic controls was unexpected. The initial clearance of both CM and VLDL are therefore quantitatively unrelated to postheparin LPL activity. One must postulate a derangement in the initial step in the metabolism of both VLDL and CM before hydrolysis by LPL in the nephrotic syndrome. The defect may be in their binding to the vascular endothelium.
The observation that dietary protein modulates albumin synthesis without effecting a change in blood lipid levels in normal rats strongly suggests that albumin synthesis is unrelated to lipid metabolism. Furthermore, the observation that blood lipid levels were increased only slightly and not significantly in nephrotic HPNE compared to the nonnephrotic LPC animals although the rate of albumin synthesis was nearly threefold higher in HPNE, again provides strong evidence that albumin synthesis is not causally linked to increased blood lipid levels.
While proteinuria was less in HPNE than in HPN, proteinuria was significantly greater in HPNE than in LPN, yet plasma TG concentration was significantly greater and cholesterol concentration tended to be greater in LPN. One reason for the greater blood lipid levels in LPN may rest in the fact that this group was consuming a high carbohydrate diet, a diet that would be expected to increase serum TG concentration. It is also possible that a higher serum r in HPNE, compared to LPN, may have contributed to normalizing blood lipid levels in HPNE. Within the nephrotic SD group, dietary protein augmentation resulted in increased blood lipid levels only when the renal clearance of albumin increased and serum albumin concentration did not. The effect of dietary protein supplementation on the rate of albumin synthesis was not predictive of its effect on blood lipid levels. While these observations do not exclude an independent effect of serum 7r on the modulation of blood lipid levels in nephrotic animals, we show that increased blood lipids occur without a parallel increase in the synthesis of the most abundant secretory protein, albumin. The observation that infusion of dextran, a nonalbumin oncotically active substance, reduces blood lipid levels in NAR (32) as well as in nephrotic animals (33) strongly suggests that reduction in serum r, and not specifically the absence of albumin from the serum is responsible for a component of hypoalbuminemia both in nonnephrotic NAR and in the nephrotic syndrome. Furthermore, the observation that CM and VLDL are cleared normally from the blood of nonnephrotic NAR excludes a relationship between serum albumin and this aspect of hyperlipidemia as well.
The normal NAR exhibits an increase in both serum cholesterol and TG, most likely resulting from increased synthesis of lipids (15) rather than from their defective removal. The negative correlation between serum cholesterol and serum 7r (protocol 1) both in these animals and as previously reported by this laboratory in nephrotic patients (34) suggests that reduced serum r in some way stimulates the increased synthesis of lipids and lipoproteins. If serum r does indeed regulate lipogenesis, it does so quite independently of any effect on albumin metabolism.
Our findings indicate that albumin plays no essential role in maintaining a normal rate of lipid removal and are consistent with the hypothesis that one component of nephrotic hyperlipidemia, reduced removal of lipids from blood, results from the urinary loss ofa liporegulatory substance in the urine; and that this substance is not albumin. Furthermore, although reduced serum r may directly stimulate the synthesis of lipids or of lipoproteins by mechanisms yet to be elucidated, there is no relationship between augmented albumin synthesis and hyperlipidemia. In addition, these data strongly suggest that the reduced clearance of CM and VLDL is not related to reduced postheparin LPL activity in nephrotic rats.
